Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 21:7:469.
doi: 10.3389/fbioe.2019.00469. eCollection 2019.

Growth Factor Engineering Strategies for Regenerative Medicine Applications

Affiliations
Review

Growth Factor Engineering Strategies for Regenerative Medicine Applications

Xiaochen Ren et al. Front Bioeng Biotechnol. .

Abstract

Growth factors are critical molecules for tissue repair and regeneration. Therefore, recombinant growth factors have raised a lot of hope for regenerative medicine applications. While using growth factors to promote tissue healing has widely shown promising results in pre-clinical settings, their success in the clinic is not a forgone conclusion. Indeed, translation of growth factors is often limited by their short half-life, rapid diffusion from the delivery site, and low cost-effectiveness. Trying to circumvent those limitations by the use of supraphysiological doses has led to serious side-effects in many cases and therefore innovative technologies are required to improve growth factor-based regenerative strategies. In this review, we present protein engineering approaches seeking to improve growth factor delivery and efficacy while reducing doses and side effects. We focus on engineering strategies seeking to improve affinity of growth factors for biomaterials or the endogenous extracellular matrix. Then, we discuss some examples of increasing growth factor stability and bioactivity, and propose new lines of research that the field of growth factor engineering for regenerative medicine may adopt in the future.

Keywords: biomaterials; extracellular matrix; growth factors; protein engineering; regenerative medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
GF engineering strategies in regenerative medicine. Strategies to control spatial and temporal presentations (A), stability (B), and signaling (C).

References

    1. Aldag C., Nogueira Teixeira D., Leventhal P. S. (2016). Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature. Clin. Cosmet. Investig. Dermatol. 9, 411–419. 10.2147/CCID.S116158 - DOI - PMC - PubMed
    1. Alvarez-Sola G., Uriarte I., Latasa M. U., Fernandez-Barrena M. G., Urtasun R., Elizalde M., et al. . (2017). Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. Gut 66, 1818–1828. 10.1136/gutjnl-2016-312975 - DOI - PubMed
    1. Beenken A., Mohammadi M. (2009). The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235–253. 10.1038/nrd2792 - DOI - PMC - PubMed
    1. Boonrungsiman S., Gentleman E., Carzaniga R., Evans N. D., McComb D. W., Porter A. E., et al. . (2012). The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc. Natl. Acad. Sci. U.S.A. 109, 14170–14175. 10.1073/pnas.1208916109 - DOI - PMC - PubMed
    1. Bouyer M., Guillot R., Lavaud J., Plettinx C., Olivier C., Curry V., et al. . (2016). Surface delivery of tunable doses of BMP-2 from an adaptable polymeric scaffold induces volumetric bone regeneration. Biomaterials 104, 168–181. 10.1016/j.biomaterials.2016.06.001 - DOI - PMC - PubMed

LinkOut - more resources